Clinical Trial Update: Oral Nitrite in Patients With Pulmonary Hypertension and Heart Failure With Preserved Ejection Fraction [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating oral nitrite in patients with pulmonary hypertension and heart failure with preserved ejection fraction has completed. Results were p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Preserved Ejection Fraction
• Pulmonary Hypertension

Drugs mentioned

• Oral nitrite (nitrite)

Snippet

Sponsor: University of Pittsburgh | Conditions: Pulmonary Hypertension Secondary, Heart Failure | Phase 2 | Status: COMPLETED | Results posted: 2024-06-07